{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:58:18Z","timestamp":1792090698364,"version":"4.4.0"},"reference-count":41,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100008363","name":"Kr\u00e6ftens Bek\u00e6mpelse","doi-asserted-by":"publisher","award":["R321\u2010A17497"],"award-info":[{"award-number":["R321\u2010A17497"]}],"id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Intern Med"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Whether aspirin or non\u2010aspirin non\u2010steroidal anti\u2010inflammatory drugs (NSAIDs) initiation may unmask unknown bladder cancers (BCs) by hematuria remains controversial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate unmasking, we compared cystoscopy rates, BC prevalence at cystoscopy, and invasive stage prevalence at diagnosis in aspirin or NSAID initiators with never\u2010users.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using the Danish population\u2010based registries, we identified all new aspirin or NSAID users in 2005\u20132023 and a matched never\u2010using comparison cohort. Second, we identified all first\u2010time cystoscopy recipients in 2005\u20132022 with aspirin or NSAID initiation within 1 year prior or never\u2010use in 10 years preceding cystoscopy. Comparing these groups, we computed hazard ratios of cystoscopy during 1\u2010year follow\u2010up, prevalence ratios of BC at cystoscopy, and invasive stage disease at diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 50,771 aspirin initiators (median age: 67 years, 51% men) and 156,191 NSAID initiators (age: 45 years, 50% men) adjusted hazard ratios of cystoscopy were 1.54 (95% confidence interval [CI]: 1.38\u20131.72) and 1.56 (95% CI: 1.43\u20131.70) compared with never\u2010users. Cystoscopy recipients included 683 aspirin (age: 70 years, 69% men) and 1414 NSAID initiators (age: 60 years, 63% men); standardized morbidity ratio weighted (SMRW) prevalence ratios were 0.97 (95% CI, 0.76\u20131.22) and 0.65 (95% CI, 0.51\u20130.82) compared with never\u2010users. The SMRW invasive stage prevalence ratios were 0.81 (95% CI, 0.63\u20131.03) and 1.07 (95% CI, 0.85\u20131.34) in the aspirin and NSAID comparison.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The combination of more cystoscopies and a lower prevalence of invasive stage at BC diagnosis may suggest the unmasking of asymptomatic BC in aspirin initiators. We did not find indications of unmasking with NSAID initiation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/joim.70115","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T08:01:25Z","timestamp":1780300885000},"page":"193-203","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Aspirin or non\u2010steroidal anti\u2010inflammatory drug initiation and subsequent bladder cancer evaluation"],"prefix":"10.1111","volume":"300","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-3194-3868","authenticated-orcid":false,"given":"Malene S\u00f6th","family":"Hansen","sequence":"first","affiliation":[{"name":"Department of Clinical Epidemiology Aarhus University Hospital  Aarhus Denmark"},{"name":"Department of Clinical Medicine Aarhus University  Aarhus Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Dyrskj\u00f8t","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine Aarhus University  Aarhus Denmark"},{"name":"Department of Molecular Medicine Aarhus University Hospital  Aarhus Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8407-4618","authenticated-orcid":false,"given":"Uffe","family":"Heide\u2010J\u00f8rgensen","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology Aarhus University Hospital  Aarhus Denmark"},{"name":"Department of Clinical Medicine Aarhus University  Aarhus Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rgen Bjerggaard","family":"Jensen","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine Aarhus University  Aarhus Denmark"},{"name":"Department of Urology Aarhus University Hospital  Aarhus Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6110-5891","authenticated-orcid":false,"given":"Mette","family":"N\u00f8rgaard","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology Aarhus University Hospital  Aarhus Denmark"},{"name":"Department of Clinical Medicine Aarhus University  Aarhus Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.13.04109"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp15X687421"},{"key":"e_1_2_10_5_1","unstructured":"Forl\u00f8bsbeskrivelse for H\u00e6matur.https:\/\/www.sundhed.dk\/sundhedsfaglig\/information\u2010til\u2010praksis\/hovedstaden\/almen\u2010praksis\/patientforloeb\/forloebsbeskrivelser\u2010icpc\/u\u2010urinveje\/haematuri\/."},{"issue":"6","key":"e_1_2_10_6_1","first-page":"11391","article-title":"Does antithrombotic use enable earlier diagnosis of bladder cancer? A brief institutional assessment","volume":"29","author":"Shah YB","year":"2022","journal-title":"Can J Urol."},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.prostaglandins.2020.106409"},{"key":"e_1_2_10_8_1","first-page":"68","article-title":"Medications mostly associated with hematuria: assessment of the EudraVigilance and Food and Drug Administration pharmacovigilance databases entries","volume":"76","author":"Cicione A","year":"2023","journal-title":"Minerva Urol Nephrol."},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(99)00388-X"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.13890"},{"issue":"1","key":"e_1_2_10_11_1","first-page":"33","article-title":"The impact of antithrombotic therapy on the time of detection of bladder cancer","volume":"76","author":"Jakus D","year":"2023","journal-title":"Cent European J Urol."},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2015.08.003"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000038228"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djad231"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70112-2"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4156-5"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djaa114"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.1.47"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33311"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0070008"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds113"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.633462"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwq437"},{"issue":"50","key":"e_1_2_10_24_1","first-page":"4581","article-title":"[Selective COX\u20102 inhibitors\u2013side effects in relation to non\u2010specific non\u2010steroidal anti\u2010inflammatory drugs]","volume":"166","author":"Hansen JM","year":"2004","journal-title":"Ugeskr Laeger."},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S179083"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-014-9930-3"},{"issue":"3","key":"e_1_2_10_27_1","first-page":"798","article-title":"Data resource profile: the Danish National Prescription Registry","volume":"46","author":"Potteg\u00e5rd A","year":"2017","journal-title":"Int J Epidemiol."},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1177\/1403494810387965"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S91125"},{"key":"e_1_2_10_30_1","first-page":"51","article-title":"Existing data sources for clinical epidemiology: the Danish National Pathology Registry and Data Bank","volume":"2","year":"2010","journal-title":"Clin Epidemiol."},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S164456"},{"key":"e_1_2_10_32_1","unstructured":"Link to DaBlaCa.Algorithm description:https:\/\/www.rkkp\u2010dokumentation.dk\/Public\/PopulationsSpecifikation21.aspx?db2=1000000862;https:\/\/www.db-dokumentation-sundk.dk\/Public\/Databases.aspx?db2=1000000994."},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3434"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-93179-8"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcvp\/pvaa073"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4385"},{"key":"e_1_2_10_37_1","unstructured":"Link to Danish Bladder Cancer (DaBlaCa).Annual report 2024.https:\/\/www.sundk.dk\/media\/ak5em332\/dablaca_aarsrapport\u20102024_offentliggjort\u201027022025.pdf."},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2007.11.054"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16234100"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S311450"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2020.02.47"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.1142"}],"container-title":["Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/joim.70115","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/joim.70115","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/joim.70115","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T18:40:33Z","timestamp":1783017633000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/joim.70115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1111\/joim.70115"],"URL":"https:\/\/doi.org\/10.1111\/joim.70115","archive":["Portico"],"relation":{},"ISSN":["0954-6820","1365-2796"],"issn-type":[{"value":"0954-6820","type":"print"},{"value":"1365-2796","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]},"assertion":[{"value":"2026-06-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}